Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cambridge Heart, Inc.
Cambridge Heart Announces Date of 2009 Annual Meeting of Stockholders
May 17th, 2009
Cambridge Heart, Inc. (OTCBB: CAMH), announced that its Annual Meeting of Stockholders will be held on Monday, June 29, 2009, at 8:30 a.m. Eastern Time, at the offices of Nutter, McClennen & Fish, LLP, World Trade Center West, 155 Seaport Boulevard, Boston, Massachusetts. About Cambridge Heart, Inc. Cambridge Heart develops and commercializes non-invasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest (SCA). The Company’s products incorporate proprietary Microvolt T-Wave Alternans™ measurement technologies, including the patented Analytic Spectral Method® and ultrasensitive disposable electrode sensors. The Company’s MTWA test,...
Source: Pharma Investments, Ventures & Law Weekly (2009-05-17)
|
